Common enzyme deficiency may hinder plans to eradicate malaria
Tuesday, November 13, 2012 - 21:30
in Health & Medicine
In malaria-endemic countries, 350 million people are predicted to be deficient in an enzyme that means they can suffer severe complications from taking primaquine, a key drug for treating relapsing malaria, according to a new study.